DICE 2: a further investigation of the effects of chance in life, death and subgroup analyses
- PMID: 11406908
DICE 2: a further investigation of the effects of chance in life, death and subgroup analyses
Abstract
In an investigation into how chance might influence the distribution of deaths in a randomised trial and the time of those deaths, and to highlight the possible dangers of subgroup analyses, 100 randomised controlled trials were simulated and 50 subgroup pairs were simulated for some of these trials. Each of 580 control patients from a colorectal cancer trial was randomly coded to simulate allocation to treatment or control, the main outcome measure being time to death. Not surprisingly, most of the 100 trials gave non-significant results. Four were conventionally significant with logrank 2p-values of less than 0.05. The most extreme result was associated with a logrank 2p-value of 0.003, showing an absolute reduction in four-year mortality of 40% (SD 15) for patients allocated to treatment. One of the simulated prognostic factors for this trial (subgroup 13) showed that mortality for one type of patient was non-significantly slightly increased by treatment, whereas treatment reduced four-year mortality by 64% (SD 16) among the other patients in the trial (2p = 0.00006). Similar, extreme results were found for a trial of borderline statistical significance overall. Chance can influence the overall results of any randomised controlled trial, regardless of how well it is conducted, and can play an even more powerful role in the results of subgroup analyses. This should be borne in mind both by trialists when reporting their results and by readers and reviewers of those reports.
Similar articles
-
Dicing with chance, life and death in systematic reviews and meta-analyses: D.I.C.E. 3, a simulation study.J R Soc Med. 2014 Mar;107(3):116-9. doi: 10.1177/0141076813514574. Epub 2014 Feb 13. J R Soc Med. 2014. PMID: 24526461 Free PMC article.
-
Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial.Am Heart J. 2001 Sep;142(3):502-11. doi: 10.1067/mhj.2001.117600. Am Heart J. 2001. PMID: 11526365 Clinical Trial.
-
The influence of the surgeon's and the hospital's caseload on survival and local recurrence after colorectal cancer surgery.Surgery. 2006 Mar;139(3):296-304. doi: 10.1016/j.surg.2005.08.023. Surgery. 2006. PMID: 16546492
-
The miracle of DICE therapy for acute stroke: fact or fictional product of subgroup analysis?BMJ. 1994 Dec 24-31;309(6970):1677-81. doi: 10.1136/bmj.309.6970.1677. BMJ. 1994. PMID: 7819982 Free PMC article.
-
[Chance occurrence in illness].Wien Med Wochenschr. 1993;143(13):347-51. Wien Med Wochenschr. 1993. PMID: 8237025 German.
Cited by
-
Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reports.Arthritis Res Ther. 2005;7(3):R644-65. doi: 10.1186/ar1704. Epub 2005 Mar 24. Arthritis Res Ther. 2005. PMID: 15899051 Free PMC article.
-
How useful are systematic reviews for informing palliative care practice? Survey of 25 Cochrane systematic reviews.BMC Palliat Care. 2008 Aug 20;7:13. doi: 10.1186/1472-684X-7-13. BMC Palliat Care. 2008. PMID: 18715496 Free PMC article.
-
The true meaning of DICE: don't ignore chance effects.J R Soc Med. 2021 Dec;114(12):575-577. doi: 10.1177/01410768211064102. J R Soc Med. 2021. PMID: 34935558 Free PMC article. No abstract available.
-
Dicing with chance, life and death in systematic reviews and meta-analyses: D.I.C.E. 3, a simulation study.J R Soc Med. 2014 Mar;107(3):116-9. doi: 10.1177/0141076813514574. Epub 2014 Feb 13. J R Soc Med. 2014. PMID: 24526461 Free PMC article.
-
Physiotherapy versus placebo or no intervention in Parkinson's disease.Cochrane Database Syst Rev. 2013 Sep 10;2013(9):CD002817. doi: 10.1002/14651858.CD002817.pub4. Cochrane Database Syst Rev. 2013. PMID: 24018704 Free PMC article.
MeSH terms
LinkOut - more resources
Medical